Search Results - "Hundalani, Shilpa G"

The influence of free hemoglobin and bilirubin on heparin monitoring by activated partial thromboplastin time and anti-Xa assay by Kostousov, Vadim, Nguyen, Kim, Hundalani, Shilpa G, Teruya, Jun

“…Elevated free hemoglobin (Hb) and bilirubinemia complicate extracorporeal membrane oxygenation and could affect unfractionated heparin (UH) therapy monitoring…”
Get full text

Prostaglandin E1 for maintaining ductal patency in neonates with ductal-dependent cardiac lesions by Akkinapally, Smita, Hundalani, Shilpa G, Kulkarni, Madhulika, Fernandes, Caraciolo J, Cabrera, Antonio G, Shivanna, Binoy, Pammi, Mohan

“…Prostaglandin E1 (PGE1) is used to keep the ductus arteriosus patent and can be life-saving in neonates with ductal-dependent cardiac lesions. PGE1 is used to…”
Get more information

Development and validation of a simple algorithm for initiation of CPAP in neonates with respiratory distress in Malawi by Hundalani, Shilpa G, Richards-Kortum, Rebecca, Oden, Maria, Kawaza, Kondwani, Gest, Alfred, Molyneux, Elizabeth

“…Low-cost bubble continuous positive airway pressure (bCPAP) systems have been shown to improve survival in neonates with respiratory distress, in developing…”
Get more information

Age-based difference in activation markers of coagulation and fibrinolysis in extracorporeal membrane oxygenation by Hundalani, Shilpa G, Nguyen, Kim T, Soundar, Esther, Kostousov, Vadim, Bomgaars, Lisa, Moise, Alicia, Hui, Shiu-Ki R, Teruya, Jun

“…Coagulation system activation in extracorporeal membrane oxygenation results in hemostatic derangements. Thrombin generation markers like prothrombin fragment…”
Get full text

Breastfeeding among inner-city women: from intention before delivery to breastfeeding at hospital discharge by Hundalani, Shilpa G, Irigoyen, Matilde, Braitman, Leonard E, Matam, Ramesh, Mandakovic-Falconi, Stefan

“…This study assessed the degree to which women's intention to breastfeed prior to delivery translates to actual breastfeeding at hospital discharge and to…”
Get more information

Efficacy and safety of Mitoxantrone, as an initial therapy, in multiple sclerosis: Experience in an Indian tertiary care setting by Singhal, B S, Geeta, Sheth, Hundalani, Shilpa G, Menon, Suresh

“…Background and Purpose : Mitoxantrone is an approved disease modifying agent for treatment of multiple sclerosis (MS). The aim of the study was to assess its…”
Get full text